America China Congress Economy Finance Healthcare Manufacturing Medicine Pharmaceutical Retail Supply Chain United States USA
Our health care system is facing a silent crisis — generic medication shortages. The severity of this crisis transcends partisan politics and demands immediate, unified action to increase generic drug production right here in America. Countless patients across the country are unable to receive life-saving treatments for severe diseases, including cancer, in a timely manner. The American Cancer Society warns that patients could experience worse health outcomes if these shortages continue. That should strike urgency in all of us. Furthermore, our hospitals face challenges in procuring essential medications, ranging from poison antidotes to vital fluids for surgeries. Even basic medicines…
News Timeline:
Track the development of this news story across the Internet.